These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Datapoints: Diabetes prevalence among persons with serious mental illness and developmental disability. Lunsky Y; Lin E; Balogh R; Klein-Geltink J Psychiatr Serv; 2011 Aug; 62(8):830. PubMed ID: 21807822 [No Abstract] [Full Text] [Related]
6. Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes: response to Lean and Pajonk. Hardy T; Breier A Diabetes Care; 2003 Nov; 26(11):3200-1. PubMed ID: 14578278 [No Abstract] [Full Text] [Related]
7. Antipsychotics and diabetes: case reports and cohort studies. Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):59-71. PubMed ID: 19667653 [TBL] [Abstract][Full Text] [Related]
8. The relationship between severe mental illness and diabetes. Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):40-5. PubMed ID: 19667652 [TBL] [Abstract][Full Text] [Related]
9. Screening for type 2 diabetes mellitus in patients with mental illness: application of a self-assessment score for diabetes mellitus risk. Shin JK; Shortridge-Baggett LM; Sachmechi I; Barron C; Chiu YL; Bajracharya B; Bang H Psychiatry Res; 2014 Dec; 220(3):1037-42. PubMed ID: 25223258 [TBL] [Abstract][Full Text] [Related]
10. Safety of antipsychotics in people with intellectual disability. Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867 [TBL] [Abstract][Full Text] [Related]
11. Quality of care for cardiovascular disease and diabetes amongst individuals with serious mental illness and those using antipsychotic medications. Scott D; Platania-Phung C; Happell B J Healthc Qual; 2012; 34(5):15-21. PubMed ID: 22092725 [TBL] [Abstract][Full Text] [Related]
12. Barriers to metabolic care for adults with serious mental illness: provider perspectives. McDonell MG; Kaufman EA; Srebnik DS; Ciechanowski PS; Ries RK Int J Psychiatry Med; 2011; 41(4):379-87. PubMed ID: 22238842 [TBL] [Abstract][Full Text] [Related]
13. [The appearance of metabolic syndrome in treatment with atypical antipsychotics]. Mosolov SN; Kabanov SO Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):62-9. PubMed ID: 14681970 [No Abstract] [Full Text] [Related]
15. Effects of antipsychotic medications on appetite, weight, and insulin resistance. Deng C Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886 [TBL] [Abstract][Full Text] [Related]
16. The patient's perspective on medicines in mental illness. Shooter M BMJ; 2003 Oct; 327(7419):824-6. PubMed ID: 14551067 [No Abstract] [Full Text] [Related]
17. Pediatric drug research and mental illness. Sallee FR FDA Consum; 2003; 37(1):40. PubMed ID: 12625307 [No Abstract] [Full Text] [Related]
18. Antipsychotic medicine and mental health. Blackburn P Ment Health Today; 2011; ():25-7. PubMed ID: 22043516 [No Abstract] [Full Text] [Related]
19. Metabolic monitoring for patients treated with antipsychotic medications. Cohn TA; Sernyak MJ Can J Psychiatry; 2006 Jul; 51(8):492-501. PubMed ID: 16933586 [TBL] [Abstract][Full Text] [Related]
20. Primary care issues in patients with mental illness. Kiraly B; Gunning K; Leiser J Am Fam Physician; 2008 Aug; 78(3):355-62. PubMed ID: 18711951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]